SABS

SAB Biotherapeutics, Inc. $3.35 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.4%
Next 1 week
-2.1%
Next 1 month
+2.5%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Deeply overbought — RSI(2) at 95
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -1.34%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.96 +2.4% · Seasonal tilt (4y) +0.1%
$2M/day volume 61% volatility +10% 1-year
52-week range · 34% of the way up · -35% from the high
$2.44$5.15

Earnings Full history →

Next report 2026-11-05 (Thursday, before open, in 5 days) · EPS est. -0.27.

1-day std dev
9.8%
Finished up
47%
Biggest pop
+15.6%
Biggest drop
-17.2%

Standard deviation of the close-to-close move over the last 19 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-06 miss -0.28 -0.28 -1.0% -0.3% +2.1% -0.5%
2026-03-09 miss -0.17 -0.41 -142.1% +5.5% +6.8% +6.0%
2025-11-14 beat -0.46 0.50 +209.1% -2.3% +4.5% +27.4%
2025-08-07 miss -0.80 -1.09 -36.9% +2.1% +1.8% +0.9%
2025-05-09 beat -1.07 -0.56 +47.8% -2.7% +4.1% +7.6%
2025-03-31 beat -1.21 -0.98 +18.9% -0.3% -8.1% -25.0%
2024-11-06 miss -1.09 -1.12 -2.6% +0.0% -17.2% -6.3%
2024-08-08 beat -1.15 -0.79 +31.1% -4.1% -12.9% -10.5%
2024-05-20 miss -0.98 -1.14 -15.9% -13.0% -15.7% -18.3%
2024-03-29 miss -0.64 -6.39 -898.7% -0.7% -5.5% -1.8%
2023-11-13 beat -1.15 -1.01 +12.4% +0.0% -2.2% -5.2%
2023-08-21 beat -1.45 -1.29 +10.8% +9.1% +3.8% -20.1%
2023-05-15 miss -1.00 -1.48 -47.6% -1.1% -11.4% +0.8%
2023-04-14 miss -1.15 -1.81 -57.2% -0.8% +6.1% +1.5%
2022-11-14 miss -1.10 -1.83 -66.0% -0.8% -15.2% -13.6%
2022-08-10 miss -1.00 -1.50 -50.5% +1.7% -2.6% -3.5%
2022-05-12 miss -1.10 -1.35 -22.8% +3.4% +11.2% +7.3%
2022-03-29 miss -0.75 -3.40 -352.8% +2.2% +15.6% +17.8%
2021-11-22 miss -0.60 -1.20 -100.0% +0.9% -13.1% +13.5%

Not investment advice.